Sino Biopharmaceutical Market Cap

Sino Biopharmaceutical has a market cap or net worth of 81.66 billion as of June 18, 2026. Its market cap has increased by 8.91% in one year.

Market Cap

81.66B

Enterprise Value

86.69B

Revenue

35.43B

Ranking

n/a

PE Ratio

31.71

Stock Price

4.58

Market Cap Chart

Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 81.66B, an increase of 24,646.91%. That is a compound annual growth rate of 23.88%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2026	81.66B	-26.09%
Dec 31, 2025	110.48B	89.64%
Dec 31, 2024	58.26B	-8.75%
Dec 29, 2023	63.85B	-24.41%
Dec 30, 2022	84.46B	-17.53%
Dec 31, 2021	102.41B	-27.33%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeOne Medicines AG	228.81B
Innovent Biologics	130.11B
WuXi Biologics	123.43B
Sichuan Kelun-Biotech Biopharmaceutical	94.07B
Akeso	80.65B
RemeGen	58.80B
3SBio	40.16B
Biocytogen Pharmaceuticals (Beijing)	38.83B

Market Cap Rankings